Role of the IkB kinase complex in oncogenic ras- and raf-mediated transformation of rat liver epithelial cells

Molecular and Cellular Biology

Volumn 20, Issue 15, 2000, Pages 5381-5391

  Arsura, Marcello ^a   Mercurio, Frank ^b   Oliver, Aundrea L ^a   Thorgeirsson, Snorri S ^c   Sonenshein, Gail E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CELGENE CORPORATION   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; RAF PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL KILLING; CELL TRANSFORMATION; COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; GROWTH INHIBITION; HALF LIFE TIME; LIVER CELL; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; ANIMAL; CELL DIVISION; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM; GENETICS; LIVER; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; GENES, RAS; I-KAPPA B PROTEINS; LIVER; NF-KAPPA B; ONCOGENE PROTEINS V-RAF; PHOSPHORYLATION; RATS; RETROVIRIDAE PROTEINS, ONCOGENIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033623830     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.15.5381-5391.2000     Document Type: Article

References (81)

1. Arsura, M., M. J. FitzGerald, N. Fausto, and G. E. Sonenshein. 1997. NF-κB/Rel blocks transforming growth factor-β1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ. 8:1049-1059.
2. Arsura, M., M. Wu, and G. E. Sonenshein. 1996. TGF-β1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of IKB-α. Immunity 5:31-40.
3. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
4. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
5. Ballard, D., E. Dixon, N. Peffer, H. Bogard, S. Doerre, B. Stein, and W. Greene. 1992. The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc. Natl. Acad. Sci. USA 85:1875-1880.
6. Bargou, R. C., F. Emmerich, D. Krappmann, M. Y. Mapara, W. Arnold, H. D. Royer, E. Grinstein, A. Greiner, C. Scheidereit, and B. Dorken. 1997. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Investig. 100: 2961-2969.
7. Bedossa, P., E. Peltier, B. Terris, D. Franco, and T. Poynard. 1995. Transforming growth factor β1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21:760-766.
8. Beg, A., W. Sha, R. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170.
9. Beg, A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α induced cell death. Science 274:782-784.
10. Bellas, R. E., M. J. FitzGerald, N. Fausto, and G. E. Sonenshein. 1997. Inhibition of NF-κB activity induces apoptosis in murine hepatocytes. Am. J. Pathol. 152:891-896.
11. Brown, K., S. Gerstenberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific signal-induced phosphorylation. Science 267:1485-1488.
12. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκB-γ by a novel ubiquitination-dependent protein kinase activity. Cell 84: 853-862.
13. Cherrington, J. M., and E. S. Mocarski. 1989. Human cytomegalovirus ie 1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J. Virol. 63:1435-1440.
14. Cui, W., D. J. Fowlis, S. Bryson, E. Duffic, H. Ireland, A. Balman, and R. J. Akhurst. 1996. TGF-β 1 inhibits the formation of benign skin tumors but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542.
15. Czaja, M. J., F. R. Weiner, K. C. Flanders, R. Giambrone, L. Wind, L. Biempica, and M. A. Zern. 1989. In vitro and in vivo association of transforming growth factor β1 with hepatic fibrosis. J. Cell Biol. 108:2477-2482.
16. Delhase, M., M. Hayakawa, Y. Chen, and M. Karin. 1999. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284:309-313.
17. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
18. DiDonato, J., A. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
19. Duprez, D., E. J. Bell, M. K. Richardson, C. W. Archer, L. Wolpert, P. M. Brickell, and P. H. Francis-West. 1996. Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb. Mech. Dev. 57:145-157.
20. Duyao, M. P., A. J. Buckler, and G. E. Sonenshein. 1990. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. USA 87:4727-4731.
21. Evarts, R. P., P. Nagy, H. Nakatsukasa, E. Marsden, and S. S. Thorgeirsson. 1989. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res. 49:1541-1547.
22. Fausto, N. 1991. Growth factors in liver development, regeneration and carcinogenesis. Prog. Growth Factor Res. 3:219-234.
23. Fausto, N., J. E. Mead, P. A. Gruppuso, and L. Braun. 1990. TGF-β in liver development, regeneration, and carcinogenesis. Ann. N.Y. Acad. Sci. 593: 231-242.
24. Finco, T. S., and A. S. Baldwin, Jr. 1993. κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires raf-1. J. Biol. Chem. 268:17676-17679.
25. Finco, T. S., J. K. Westwick, J. L. Norris, A. A. Beg, C. J. Der, and A. S. Baldwin, Jr. 1997. Oncogenic Ha-Ras-induced signalling activates NF-κB transcriptional activity. which is required for cellular transformation. J. Biol. Chem. 272:24113-24116.
26. Fynn, T. M., and M. Reiss. 1993. Resistance to inhibition of cell growth by transforming growth factor A and its role in oncogenesis. Crit. Rev. Oncog. 4:493-540.
27. Garfield, S., B. E. Huber, P. Nagy, M. G. Cordingley, S. S. Thorgeirsson. 1988. Neoplastic transformation and lineage switching of rat liver epithelial cells by retrovirus-associated oncogenes. Mol. Carcinog. 1:189-195.
28. Geleziunas, R., S. Ferrell, X. Lin, Y. Mu, E. T. Cunningham, Jr., M. Grant, M. A. Connelly, J. E. Hambor, K. B. Marcu, and W. C. Greene. 1998. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase alpha (IKKα) and IKKβ cellular kinases. Mol. Cell. Biol. 18: 5257-5265.
29. Gilmore, T. D., M. Koedood, K. A. Piffat, and D. W. White. 1996. Rel/NF-κB/IκB protein and cancer. Oncogene 13:1367-1378.
30. Giri, D. K., and B. B. Aggarwal. 1998. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells: autocrine role of tumor necrosis factor and reactive oxygen intermediates. J. Biol. Chem. 273:14008-14014.
31. Grisham, J. W., and S. S. Thorgeirsson. 1997. Liver stem cells, p. 233-282. In C. S. Potten (ed.), Stem cells. Academic Press, London, United Kingdom.
32. Hampton, L. L., P. J. Worland, B. Yu, S. S. Thorgeirsson, and A. C. Huggett. 1490. Expression of growth-related genes during tumor progression in v-raf-transformed rat liver epithelial cells. Cancer Res. 50:7460-7467.
33. Houck, K. A., G. K. Michalopoulos, and S. C. Strom. 1989. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-β. Oncogene 4: 19-25.
34. Howe, P. H., S. F. Dobrowolski, K. B. Reddy, and D. W. Stacey. 1993. Release from G1 growth arrest by transforming growth factor β1 requires cellular ras activity. J. Biol. Chem. 268:21448-21452.
35. Hu, Y., V. Baud, M. Delhase, P. Zhang, T. Deerinck, M. Ellisman, R. Johnson, and M. Karin. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284:316-320.
36. Huggett, A. C., L. L. Hampton, C. P. Ford, P. J. Wirth, and S. S. Thorgeirsson. 1989. Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their transformation with v-raf. Cancer Res. 50:7468-7465.
37. Kalkuhl, A., J. Troppmair, A. Buchmann, S. Stinchcombe, C. L. Buenemann, U. R. Rapp, K. Kaestner, and M. Schwarz. 1998. p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions. Hepatology 27:1081-1088.
38. Kim, D. W., M. A. Sovak, G. Zanieski, G. Nonet, R. Romieu-Mourez, A. W. Lau, L. J. Hafer, P. Yaswen, M. Stampfer, A. E. Rogers, J. Russo, and G. E. Sonenshein. 2000. Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21:871-879.
39. Kolch, W., G. Heidecker, G. Kochs, R. Hummel, H. Vahidi, H. Mischack, G. Finkenzeller, D. Marme, and U. R. Rapp. 1993. Protein kinase C alpha activates Raf-1 by direct phosphorylation. Nature 364:249-252.
40. Kotani, K., K. Yonezawa, K. Hara, H. Hueda, Y. Kitamura, H. Sakaue, A. Ando, A. Chavanieu, B. Calas, and F. Grigorescu. Involvement of phosphoinositide 3-kinase in insulin-or IGF-1-induced membrane ruffling. EMBO J. 13:2313-2321.
41. Krams, S. M., H. Egawa, M. B. Quinn, J. C. Villanueva, R. Garcia-Kennedy, and O. M. Martinez. 1995. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 59:621-625.
42. Li, Q., D. Van Antwerp, F. Mercurio, K. F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321-325.
43. Lucito, R., and R. J. Schneider. 1992. Hepatitis B virus X protein activates transcription factor NF-κB without a requirement for protein kinase C. J. Virol. 66:983-991.
44. Malinin, N. L., M. P. Boldin, A. V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385:540-544.
45. Maronpot, R. R., T. Fox, D. E. Malarkey, and T. L. Goldsworthy. 1995. Mutations in the ras proto-oncogenes: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101:125-156.
46. Massague, J. 1996. TGF-β signaling: receptors, transducers, and Mad proteins. Cell 85:947-950.
47. Massague, J. 1990. The transforming growth factor-β family. Annu. Rev. Cell. Biol. 6:597-641.
48. May, M. J., and S. Ghosh. 1999. IkappaB kinases: kinsmen with different crafts. Science 284:271-273.
49. Mayo, M. W., C.-Y. Wang, P. C. Cogswell, K. S. Rogers-Graham, S. W. Lowe, C. J. Der, and A. S. Baldwin, Jr. 1997. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278: 1812-1815.
50. McMahon, J. B., W. L. Richards, A. A. del Campo, M. K. H. Song, and S. S. Thorgeirsson. 1986. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res. 46:4665-4671.
51. Mercurio, F., B. W. Murray, A. Shevchenko, B. L. Bennett, D. B. Young, J. W. Li, G. Pascual, A. Motiwala, H. Zhu, M. Mann, and A. M. Manning. 1999. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19:1526-1538.
52. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. W. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860-865.
53. Mori, N., M. Fujii, S. Ikeda, Y. Yamada, M. Tomonaga, D. W. Ballard, and N. Yamamoto. 1999. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 93:2360-2368.
54. Oberhammer, F. A., W. Bursch, W. Parzefall, P. Breit, E. Erber, M. Stadler, and R. Schulte-Hermann. 1991. Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res. 51:2478-2485.
55. Oberhammer, F. A., M. Pavelka, S. Sharma, R. Tiefenbacher, A. F. Purchio, W. Bursch, and R. Schulte-Hermann. 1992. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA 89:5408-5412.
56. O'Farrell, P. H. 1975. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 10:4007-4021.
57. Oft, M., J. Peli, C. Rudaz, H. Schwarz, H. Beug, and E. Reichmann. 1996. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10:2462-2477.
58. Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
59. Pierce, Jr., D. F., A. E. Gorska, A. Chytil, K. S. Meise, D. L. Page, R. J. Coffrey, Jr., and H. L. Moses. 1995. Mammary tumor suppression by transforming growth factor β transgenc expression. Proc. Natl. Acad. Sci. USA 92: 4254-4258.
60. Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
61. Roberts, A. B., and M. B. Sporn. 1990. The transforming growth factor-betas, p. 419-472. In M. B. Sporn and A. B. Roberts (ed.), Peptide growth factor and their receptors. Springer-Verlag, Heidelberg, Germany.
62. Rodriguez-Viciana, P., P. H. Warne, A. Khwaya, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositode 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467.
63. Romashkova, J. A., and S. S. Makarov. 1999. NF-κB is a target of Akt in anti-apoptotic PDGF signalling. Nature 410:86-90.
64. Rothwarf, D. M., E. Zandi, G. Natoli, and M. Karin. 1998. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395: 297-300.
65. Sanderson, N., V. Factor, P. Nagy, J. Kopp, P. Kondaiah, L. Wakefield, A. B. Roberts, M. B. Sporn, and S. S. Thorgeirsson. 1995. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA 92:2572-2576.
66. Schulte-Hermann, R., B. Grasl-Kraupp, and W. Bursch. 1995. Apoptosis and hepatocarcinogenesis, p. 141-177. In R. L. Jirtle (ed.), Liver regeneration and carcinogenesis: molecular and cellular mechanisms. Academic Press, San Diego, Calif.
67. Shattuck, R. L., L. D. Wood, G. J. Jaffe, and A. Richmond. 1994. MGSA/ GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells. Mol.Cell. Biol. 14:791-802.
68. Sovak, M. A., R. E. Bellas, D. W. Kim, G. J. Zanieski, A. E. Rogers, A. M. Traish, and G. E. Sonenshein. 1997. Aberrant NF-κB/Rel expression in breast cancer: a role in protection from apoptosis. J. Clin. Investig. 100:2952-2960.
69. Sumitomo, M., M. Tachibana, C. Ozu, H. Asakura, M. Murai, M. Hayakawa, H. Nakamura, A. Takayanagi, and N. Shimizu. 1999. Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression. Hum. Gene Ther. 10:37-47.
70. Sumitomo, M., M. Tachibana, J. Nakashima, M. Murai, A. Miyajima, M. Kimura, M. Hayakawa, and H. Nakamura. 1999. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. J. Urol. 161:674-679.
71. Takeda, K., O. Takeuchi, T. Tsujimura, S. Itami, O. Adachi, T. Kawai, H. Sanjo, K. Yoshikawa, N. Terada, and S. Akira. 1999. Limb and skin abnormalities in mice lacking IKKalpha. Science 284:313-316.
72. Teramoto, T., A. Kiss, and S. S. Thorgeirsson. 1998. Induction of p53 and Bax during TGF-beta 1 initiated apoptosis in rat liver epithelial cells. Biochem. Biophys. Res. Commun. 251:56-60.
73. Thorgeirsson, S. S. 1995. Target cell populations in virus-associated hepatocarcinogenesis. Princess Takamatsu Symp. 25:163-170.
74. Tsao, M. S., J. D. Smith, K. G. Nelson, and J. W. Grisham. 1984. A diploid epithelial cell line from normal adult rat liver with phenotypic properties of "oval" cells. Exp. Cell Res. 154:38-52.
75. Urban, M. B., R. Schreck, and P. Baeuerle. 1991. NF-κB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J. 10:1817-1826.
76. Van Antwerp, D. J., J. M. Seamus, T. Kafri, D. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
77. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
78. Wang, C-Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274: 784-787.
79. Wang, W., J. L. Abbruzzese, D. B. Evans, L. Larry, K. R. Cleary, and P. J. Chiao. 1999. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res. 5:119-127.
80. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. 1997. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278:866-869.
81. Wu, M., H. Lee, R. E. Bellas, S. L. Schauer, M. Arsura, D. Katz, M. J. Filz-Gerald, T. L. Rothstein, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:4682-4690.